Bhaskar Agrochemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 29, 2025, 11:40 pm

Quick Insight

Bhaskar Agrochemicals Ltd, with a share price of ₹113 and a market cap of ₹59.0 Cr, presents an intriguing investment opportunity in the agrochemicals sector. The company's price-to-earnings ratio of 10.8 indicates a reasonable valuation, coupled with a robust return on equity of 24.7% and return on capital employed of 21.3%. These figures surpass sector averages, suggesting efficient capital utilization and profitability. Furthermore, with promoters holding a significant stake of 62.28% and healthy reserves of ₹13 Cr, the company exhibits strong internal financial support and a stable ownership structure.

However, despite these strengths, Bhaskar Agrochemicals faces risks such as a relatively low operating profit margin of 3.15% and a long cash conversion cycle of 155 days, potentially signaling operational inefficiencies and liquidity challenges. Additionally, the company's reliance on borrowed funds amounting to ₹20 Cr raises concerns about debt servicing capabilities, especially with an interest coverage ratio of 2.39x. Looking ahead, improving operational efficiency, reducing the cash conversion cycle, and prudently managing debt levels could enhance Bhaskar Agrochemicals' competitive position and financial health, paving the way for sustainable growth in the agrochemicals market.

In conclusion, while Bhaskar Agrochemicals exhibits strengths in profitability and ownership structure, addressing operational inefficiencies and managing debt prudently will be crucial for its long-term success. Retail investors should closely monitor the company's efforts to improve operational metrics and enhance financial stability to capitalize on its growth potential in the agrochemicals sector.

Competitors of Bhaskar Agrochemicals Ltd

All Competitor Stocks of Bhaskar Agrochemicals Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:15 pm

Below is a detailed analysis of the quarterly data for Bhaskar Agrochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 23.20 Cr.. The value appears strong and on an upward trend. It has increased from 22.31 Cr. (Mar 2025) to 23.20 Cr., marking an increase of 0.89 Cr..
• For Expenses, as of Jun 2025, the value is 22.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20.49 Cr. (Mar 2025) to 22.47 Cr., marking an increase of 1.98 Cr..
• For Operating Profit, as of Jun 2025, the value is 0.73 Cr.. The value appears to be declining and may need further review. It has decreased from 1.82 Cr. (Mar 2025) to 0.73 Cr., marking a decrease of 1.09 Cr..
• For OPM %, as of Jun 2025, the value is 3.15%. The value appears to be declining and may need further review. It has decreased from 8.16% (Mar 2025) to 3.15%, marking a decrease of 5.01%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.06 Cr..
• For Interest, as of Jun 2025, the value is 0.48 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.74 Cr. (Mar 2025) to 0.48 Cr., marking a decrease of 0.26 Cr..
• For Depreciation, as of Jun 2025, the value is 0.43 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.45 Cr. (Mar 2025) to 0.43 Cr., marking a decrease of 0.02 Cr..
• For Profit before tax, as of Jun 2025, the value is -0.18 Cr.. The value appears to be declining and may need further review. It has decreased from 0.69 Cr. (Mar 2025) to -0.18 Cr., marking a decrease of 0.87 Cr..
• For Tax %, as of Jun 2025, the value is 16.67%. The value appears to be increasing, which may not be favorable. It has increased from -7.25% (Mar 2025) to 16.67%, marking an increase of 23.92%.
• For Net Profit, as of Jun 2025, the value is -0.21 Cr.. The value appears to be declining and may need further review. It has decreased from 0.74 Cr. (Mar 2025) to -0.21 Cr., marking a decrease of 0.95 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.40. The value appears to be declining and may need further review. It has decreased from 1.42 (Mar 2025) to -0.40, marking a decrease of 1.82.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:33 pm

Growth

Last Updated: September 5, 2025, 2:41 pm

Balance Sheet

Last Updated: September 10, 2025, 3:12 pm

Below is a detailed analysis of the balance sheet data for Bhaskar Agrochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
• For Reserves, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 4.00 Cr..
• For Borrowings, as of Mar 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 18.00 Cr. (Mar 2024) to 20.00 Cr., marking an increase of 2.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.00 Cr. (Mar 2024) to 20.00 Cr., marking an increase of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 58.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 50.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 8.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2024) to 40.00 Cr., marking an increase of 9.00 Cr..
• For Total Assets, as of Mar 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 8.00 Cr..

However, the Borrowings (20.00 Cr.) are higher than the Reserves (13.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Bhaskar Agrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.34 (Mar 24) to 7.48, marking an increase of 4.14.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.34 (Mar 24) to 7.48, marking an increase of 4.14.
• For Cash EPS (Rs.), as of Mar 25, the value is 10.82. This value is within the healthy range. It has increased from 6.40 (Mar 24) to 10.82, marking an increase of 4.42.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.07. It has increased from 26.58 (Mar 24) to 34.07, marking an increase of 7.49.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.07. It has increased from 26.58 (Mar 24) to 34.07, marking an increase of 7.49.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 173.73. It has increased from 128.21 (Mar 24) to 173.73, marking an increase of 45.52.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 17.54. This value is within the healthy range. It has increased from 11.74 (Mar 24) to 17.54, marking an increase of 5.80.
• For PBIT / Share (Rs.), as of Mar 25, the value is 14.21. This value is within the healthy range. It has increased from 8.70 (Mar 24) to 14.21, marking an increase of 5.51.
• For PBT / Share (Rs.), as of Mar 25, the value is 10.37. This value is within the healthy range. It has increased from 5.10 (Mar 24) to 10.37, marking an increase of 5.27.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.35 (Mar 24) to 7.48, marking an increase of 4.13.
• For PBDIT Margin (%), as of Mar 25, the value is 10.09. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 10.09, marking an increase of 0.93.
• For PBIT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has increased from 6.78 (Mar 24) to 8.17, marking an increase of 1.39.
• For PBT Margin (%), as of Mar 25, the value is 5.96. This value is below the healthy minimum of 10. It has increased from 3.98 (Mar 24) to 5.96, marking an increase of 1.98.
• For Net Profit Margin (%), as of Mar 25, the value is 4.30. This value is below the healthy minimum of 5. It has increased from 2.61 (Mar 24) to 4.30, marking an increase of 1.69.
• For Return on Networth / Equity (%), as of Mar 25, the value is 21.95. This value is within the healthy range. It has increased from 12.60 (Mar 24) to 21.95, marking an increase of 9.35.
• For Return on Capital Employeed (%), as of Mar 25, the value is 29.23. This value is within the healthy range. It has increased from 19.67 (Mar 24) to 29.23, marking an increase of 9.56.
• For Return On Assets (%), as of Mar 25, the value is 6.67. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 6.67, marking an increase of 3.19.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.25.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.14. This value exceeds the healthy maximum of 1. It has increased from 1.09 (Mar 24) to 1.14, marking an increase of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.67. It has increased from 1.37 (Mar 24) to 1.67, marking an increase of 0.30.
• For Current Ratio (X), as of Mar 25, the value is 1.20. This value is below the healthy minimum of 1.5. It has increased from 0.58 (Mar 24) to 1.20, marking an increase of 0.62.
• For Quick Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 24) to 0.65, marking an increase of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 7.97 (Mar 24) to 0.00, marking a decrease of 7.97.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.56. This value is within the healthy range. It has increased from 3.27 (Mar 24) to 4.56, marking an increase of 1.29.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has increased from 1.93 (Mar 24) to 2.95, marking an increase of 1.02.
• For Enterprise Value (Cr.), as of Mar 25, the value is 60.74. It has increased from 48.27 (Mar 24) to 60.74, marking an increase of 12.47.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.72 (Mar 24) to 0.67, marking a decrease of 0.05.
• For EV / EBITDA (X), as of Mar 25, the value is 6.65. This value is within the healthy range. It has decreased from 7.91 (Mar 24) to 6.65, marking a decrease of 1.26.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.44, marking a decrease of 0.02.
• For Price / BV (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 2.22 (Mar 24) to 2.29, marking an increase of 0.07.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.44, marking a decrease of 0.02.
• For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.09, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness